The estimated Net Worth of Rajeev Singh is at least $5.61 Million dollars as of 3 September 2024. Mr Singh owns over 3,786 units of Accolade stock worth over $3,083,234 and over the last 7 years he sold ACCD stock worth over $1,700,066. In addition, he makes $828,000 as Chairman & CEO at Accolade.
Mr has made over 58 trades of the Accolade stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 3,786 units of ACCD stock worth $14,803 on 3 September 2024.
The largest trade he's ever made was exercising 400,102 units of Accolade stock on 17 May 2023 worth over $1,828,466. On average, Mr trades about 12,922 units every 21 days since 2017. As of 3 September 2024 he still owns at least 788,551 units of Accolade stock.
You can see the complete history of Mr Singh stock trades at the bottom of the page.
Rajeev Singh is the Chairman & CEO at Accolade.
As the Chairman & CEO of Accolade, the total compensation of Mr Singh at Accolade is $828,000. There are no executives at Accolade getting paid more.
Mr Singh is 53, he's been the Chairman & CEO of Accolade since . There are 2 older and 3 younger executives at Accolade. The oldest executive at Accolade, Inc. is J. Michael Cline, 60, who is the Co-Founder & Independent Chairman.
Rajeev's mailing address filed with the SEC is C/O ACCOLADE, INC., , SEATTLE, WA, 98101.
Over the last 4 years, insiders at Accolade have traded over $9,006,680 worth of Accolade stock and bought 74 units worth $743 . The most active insiders traders include Edgar Jr Bronfman, Jeffrey D Jordan und Dawn G Lepore. On average, Accolade executives and independent directors trade stock every 5 days with the average trade being worth of $18,928. The most recent stock trade was executed by Rajeev Singh on 3 September 2024, trading 3,786 units of ACCD stock currently worth $14,803.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Accolade executives and other stock owners filed with the SEC include: